(A) 3-dimensional (3D) enface view of the mitral valve (MV) with the aortic valve (AV) seen in the 12 o’clock position. The mitral bioprosthesis is visualized with a paravalvular defect located posteromedially (red arrow). (B) 3D Trueview image of the mitral valve showing eccentric systolic flow through the paravalvular defect.
(A, B) A 3-dimensional enface view of the mitral valve with two Amplatzer ventricular septal defect (Abbott) devices (yellow arrow) well seated within the paravalvular defect. Panel B shows a small amount of residual paravalvular leak. AV: aortic valve; MV: mitral valve
The authors have no competing interests to declare.
Ruiz CE, Hahn RT, Berrebi A, et al. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement. J Am Coll Cardiol. 2017 Apr 25;69(16):2067-87. doi: https://doi.org/10.1016/j.jacc.2017.02.038
Duncan BF, McCarthy PM, Kruse J, et al. Paravalvular regurgitation after conventional aortic and mitral valve replacement: A benchmark for alternative approaches. J Thorac Cardiovasc Surg. 2015 Oct;150(4):860-8.e1. doi: https://doi.org/10.1016/j.jtcvs.2015.06.047
Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. New Engl J Med. 1996 Aug 8;335(6):407-16. doi: https://doi.org/10.1056/NEJM199608083350607